NUVAXOVID
Swiss trademark · 838148 · Combined mark · In force
Register entry
- Registration number
- 838148
- Application number
- 15561/2025
- Status
- In force
- Type
- Combined mark
- As registered
- NUVAXOVID ((fig.))
- Filed
- Nov 29, 2021
- Registered
- Oct 20, 2025
- Published
- Oct 20, 2025
- Protected until
- Nov 29, 2031
- Priority
- 06.07.2021 US06.07.2021 US
- Remarks
- Umwandlung der internationalen Registrierung Nr. 1641232 (Art. 46a MschG).
- Language of procedure
- German
- Vienna classes
- 26.11.02, 26.11.09, 26.11.13, 26.11.14
- Source
- Swissreg
Goods and services
Pharmaceuticals
Vaccins pour le traitement et la prévention de la Covid-19.
Science, technology and IT
Fourniture d'informations en matière de recherche médicale et scientifique dans le domaine des vaccins de Covid-19, ainsi que d'essais cliniques et d'essais post-marché en lien avec des vaccins de Covid-19; services de conseillers dans le domaine de la recherche et du développement de vaccins de Covid-19; Recherche et développement de vaccins de Covid-19.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 20, 2025
Registered
Published in Swissreg on 20.10.2025
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.